Circulation

Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era.

Circulation

Lazar LD, Pletcher MJ, Coxson PG, Bibbins-Domingo K, Goldman L

Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era.

Circulation

Lazar LD, Pletcher MJ, Coxson PG, Bibbins-Domingo K, Goldman L

Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial.

Circulation

Ensrud K, LaCroix A, Thompson JR, Thompson DD, Eastell R, Reid DM, Vukicevic S, Cauley J, Barrett-Connor E, Armstrong R, Welty F, Cummings S

Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial.

Circulation

Ensrud K, LaCroix A, Thompson JR, Thompson DD, Eastell R, Reid DM, Vukicevic S, Cauley J, Barrett-Connor E, Armstrong R, Welty F, Cummings S

Health effects of light and intermittent smoking: a review.

Circulation

Schane RE, Ling PM, Glantz SA

Health effects of light and intermittent smoking: a review.

Circulation

Schane RE, Ling PM, Glantz SA

Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Circulation

Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W

Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Circulation

Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W

Pages